Fumiaki Koizumi Selected Research

Fumiaki Koizumi Research Topics

Disease

35	Neoplasms (Cancer) 11/2022 - 03/2003
9	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2018 - 03/2003
8	Lung Neoplasms (Lung Cancer) 01/2019 - 07/2006
6	Neoplasm Metastasis (Metastasis) 11/2022 - 03/2003
5	Stomach Neoplasms (Stomach Cancer) 11/2022 - 06/2005
5	Colorectal Neoplasms (Colorectal Cancer) 05/2014 - 07/2003
3	Breast Neoplasms (Breast Cancer) 03/2016 - 02/2009
3	Glioma (Gliomas) 01/2014 - 10/2008
3	Hypoxia (Hypoxemia) 01/2014 - 01/2006
2	Triple Negative Breast Neoplasms 09/2018 - 09/2012
2	Glioblastoma (Glioblastoma Multiforme) 04/2013 - 10/2008
2	Adenocarcinoma of Lung 11/2011 - 12/2004
1	Circulating Neoplastic Cells 11/2022
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 06/2015
1	Hypertension (High Blood Pressure) 07/2014
1	Proteinuria 07/2014
1	Fatigue 07/2014
1	Bone Diseases (Bone Disease) 01/2014
1	Cachexia 01/2014
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2014
1	Ventricular Tachycardia 01/2014
1	Lewis Lung Carcinoma 01/2014
1	Pancreatic Neoplasms (Pancreatic Cancer) 06/2012
1	Lymphatic Metastasis 06/2011

Drug/Important Bio-Agent (IBA)

11	ErbB Receptors (EGF Receptor)IBA 04/2018 - 01/2004
8	Biomarkers (Surrogate Marker)IBA 01/2019 - 08/2008
8	Gefitinib (Iressa)FDA Link 06/2014 - 01/2004
7	Pharmaceutical PreparationsIBA 11/2022 - 08/2005
6	Irinotecan (Camptosar)FDA LinkGeneric 05/2008 - 01/2004
5	Tyrosine Kinase InhibitorsIBA 04/2018 - 01/2004
4	Small Interfering RNA (siRNA)IBA 01/2019 - 01/2011
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2014 - 10/2006
3	Phosphotransferases (Kinase)IBA 09/2018 - 06/2014
3	Epithelial Cell Adhesion MoleculeIBA 01/2015 - 03/2014
3	Complementary DNA (cDNA)IBA 10/2008 - 03/2003
3	MicellesIBA 05/2008 - 10/2006
2	poly ADP-ribose glycohydrolaseIBA 01/2019 - 11/2013
2	Cell-Free Nucleic AcidsIBA 04/2018 - 01/2018
2	Trastuzumab (Herceptin)FDA Link 06/2015 - 02/2009
2	lenvatinibIBA 07/2014 - 04/2011
2	DNA (Deoxyribonucleic Acid)IBA 05/2014 - 01/2014
2	Cetuximab (Erbitux)FDA Link 05/2014 - 10/2008
2	Therapeutic UsesIBA 01/2014 - 05/2008
2	epidermal growth factor receptor VIIIIBA 04/2013 - 10/2008
2	Everolimus FDA Link 09/2012 - 12/2011
2	Angiogenesis InhibitorsIBA 06/2011 - 01/2006
2	Liposomes (Liposome)IBA 12/2010 - 11/2008
2	Proteins (Proteins, Gene)FDA Link 12/2010 - 01/2004
2	Peptides (Polypeptides)IBA 12/2010 - 11/2008
2	Monoclonal AntibodiesIBA 02/2009 - 10/2008
2	vandetanib (ZD6474)IBA 01/2006 - 12/2004
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2006 - 01/2004
2	Tumor Biomarkers (Tumor Markers)IBA 01/2006 - 07/2003
1	AntigensIBA 11/2022
1	Dual-Specificity PhosphatasesIBA 01/2019
1	Alkylating AgentsIBA 01/2019
1	Cisplatin (Platino)FDA LinkGeneric 01/2019
1	Indicators and Reagents (Reagents)IBA 04/2018
1	Blood Proteins (Serum Proteins)IBA 07/2014
1	Angiogenic ProteinsIBA 07/2014
1	Chemokine CXCL12IBA 07/2014
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 07/2014
1	8- (6- methoxypyridin- 3- yl)- 3- methyl- 1- (4- piperazin- 1- yl- 3- trifluoromethylphenyl)- 1,3- dihydroimidazo(4,5- c)quinolin- 2- oneIBA 06/2014
1	TOR Serine-Threonine KinasesIBA 06/2014
1	Nuclear Proteins (Protein, Nuclear)IBA 05/2014
1	O-(6)-methylguanineIBA 01/2014
1	tocilizumab (atlizumab)FDA Link 01/2014
1	Temozolomide (Temodar)FDA LinkGeneric 01/2014
1	Zoledronic Acid (Zometa)FDA Link 01/2014
1	Saline SolutionIBA 01/2014
1	Insulin-Like PeptidesIBA 01/2014
1	MethyltransferasesIBA 01/2014
1	Mevalonic Acid (Mevalonate)IBA 01/2014
1	Verapamil (Calan)FDA LinkGeneric 01/2014
1	Interleukin-6 (Interleukin 6)IBA 01/2014
1	Monomeric GTP-Binding ProteinsIBA 01/2014
1	A-Form DNA (A-DNA)IBA 01/2014
1	enhanced green fluorescent proteinIBA 04/2013
1	AngiopoietinsIBA 04/2013
1	Transforming Growth Factors (Transforming Growth Factor)IBA 11/2012
1	Epidermal Growth Factor (EGF)IBA 11/2012
1	human ERBB2 proteinIBA 09/2012
1	Estrogen ReceptorsIBA 09/2012
1	ChemokinesIBA 06/2012
1	InterleukinsIBA 06/2012
1	Gemcitabine FDA Link 06/2012
1	Interleukin-10 (Interleukin 10)IBA 06/2012
1	EnzymesIBA 11/2011
1	Heparitin Sulfate (Heparan Sulfate)IBA 11/2011
1	ImmunosorbentsIBA 11/2011
1	LuciferasesIBA 06/2011
1	Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA 06/2011
1	Sunitinib (Sutent)FDA Link 06/2011

Therapy/Procedure

11	Therapeutics 01/2019 - 01/2004
5	Drug Therapy (Chemotherapy) 06/2015 - 11/2008
3	Radiotherapy 04/2018 - 11/2013
1	Neoadjuvant Therapy 09/2018
1	Molecular Targeted Therapy 04/2018
1	Transplantation 01/2014
1	Aftercare (After-Treatment) 06/2011